PhRMA goes on the offensive, attacking the WHO and putting the EU, UK, Australia and others on notice

Each year, industry groups like PhRMA offer their views on which countries around the globe might be harming biopharma innovation as a result of their intellectual property protections or lack thereof, which can contribute to a report produced by the White House’s trade representative on the global state of IP.


Click to view original post